
The United States market has experienced a positive trend, climbing 1.7% in the last week and showing a substantial 25% increase over the past year, with earnings projected to grow by 19% annually in the coming years. In such an environment, identifying stocks that are priced below their estimated value can be crucial for investors looking to capitalize on potential growth opportunities, as these stocks may offer significant upside potential relative to their current market price.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Tutor Perini (TPC) | $77.99 | $155.11 | 49.7% |
| Rayonier (RYN) | $20.98 | $40.70 | 48.5% |
| Mobileye Global (MBLY) | $8.46 | $16.37 | 48.3% |
| Luckin Coffee (LKNC.Y) | $30.51 | $59.48 | 48.7% |
| Live Oak Bancshares (LOB) | $38.26 | $74.21 | 48.4% |
| Lazard (LAZ) | $44.30 | $88.22 | 49.8% |
| Clear Secure (YOU) | $51.45 | $100.57 | 48.8% |
| Cactus (WHD) | $54.69 | $106.71 | 48.8% |
| BillionToOne (BLLN) | $105.15 | $203.29 | 48.3% |
| AbbVie (ABBV) | $216.49 | $431.46 | 49.8% |
We're going to check out a few of the best picks from our screener tool.
Overview: Symbotic Inc. is an automation technology company that develops technologies to enhance operating efficiencies in modern warehouses, with a market cap of $25.13 billion.
Operations: Symbotic Inc. generates its revenue from the Industrial Automation & Controls segment, amounting to $2.52 billion.
Estimated Discount To Fair Value: 42.1%
Symbotic Inc. appears undervalued, trading at US$41.68, below its estimated future cash flow value of US$71.99 and 42.1% under fair value estimates. Recent earnings show a turnaround to profitability with a net income of US$1.97 million in Q2 2026 from a prior loss, driven by strategic partnerships enhancing automation capabilities with clients like Medline and AWG, supporting robust growth prospects despite insider selling concerns.
Overview: Cellebrite DI Ltd. develops software and services for legally sanctioned investigations across multiple regions including Europe, the Middle East, Africa, the Americas, and the Asia-Pacific, with a market cap of $3.20 billion.
Operations: Cellebrite DI Ltd. generates $496.43 million in revenue from its Internet Software & Services segment, focusing on solutions for legally sanctioned investigations across various global regions.
Estimated Discount To Fair Value: 23.4%
Cellebrite DI is trading at US$12.83, below its estimated future cash flow value of US$16.74, suggesting it is undervalued by more than 20%. The company recently became profitable and forecasts earnings growth of 20.8% annually, outpacing the broader U.S. market's growth rate. Recent developments include the launch of Cellebrite Genesis, enhancing investigative capabilities with AI-driven insights and achieving FedRAMP High Authorization for its Government Cloud platform, boosting its appeal to federal agencies.
Overview: Tenable Holdings, Inc. offers cyber exposure management solutions across various regions worldwide and has a market cap of approximately $2.96 billion.
Operations: The company generates revenue of $1.02 billion from its Security Software & Services segment.
Estimated Discount To Fair Value: 43.6%
Tenable Holdings is trading at US$26.87, significantly below its estimated future cash flow value of US$47.61, indicating it is undervalued based on cash flows. The company anticipates becoming profitable within three years with earnings projected to grow at 87.32% annually, though revenue growth lags the U.S. market average. Recent advancements include enhanced AI governance and security capabilities in its Tenable One platform, aiming to improve risk management and operational efficiency for clients.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com